| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |